SEO URLwww.firestrike.ai/deals/orna-therapeutics-lilly-acquisition-2026-2
acquisitionAnnounced · Feb 9, 2026cell therapySource · CredibleArticle · Factual
Lilly acquires Orna Therapeutics
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$2.4B
Target
Orna Therapeutics
Cambridge, Massachusetts
Acquirer
Lilly
Full Acquisition
Status
Announced
Lilly agreed to acquire Orna Therapeutics. Reported deal value: $2.4B. Status: Announced. Sector: cell therapy. Target headquarters context: Cambridge, Massachusetts, United States.
This page summarizes publicly available information about the transaction as of 2026-02-09. Figures and status may change as filings and press coverage update.
Eli Lilly will buy Orna Therapeutics to get a hold of its immune system-resetting pipeline and enter the in vivo CAR -T cell therapy race
Deal timeline
Announced
Feb 9, 2026 · endpoints.news
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in cell therapy with a reported deal value of $2.4B. Figures and status may change as sources update.
Sources: endpoints.news · Primary article · FireStrike proprietary index